HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A comparative study on lysosomal accumulation of gallium-67 and indium-111 in Morris hepatoma 7316A.

Abstract
Intracellular localization of Ga-67 and In-111 was investigated in Morris hepatoma 7316A and in normal Buffalo rat liver cells by a cell fractionation method at 48 hr after an intraperitoneal injection of the nuclides. Lysosomal fractions of the tumor and normal liver cells had the highest relative specific radioactivities of the nuclides (p less than 0.001). In a gradual solubilization experiment, the release of the nuclides at the same time as the acid phosphatase from the lysosomal fractions (p less than 0.001) was thought to indicate that lysosomes are the site of accumulation for both nuclides whether in tumor or normal liver cells. Fragility of the tumor lysosomes might be inferred from the significantly greater regression coefficient in relation to the lysosomal fraction of tumor cells than that of normal liver cells when labeled with Ga-67 (p less than 0.001). The poorer confidence limit for the regression coefficient in relation to the lysosomal fraction of tumor cells labeled with Ga-67 seemed to indicate that Ga-67 determines lysosomal functions of tumor cells more precisely than In-111.
AuthorsS Takeda, T Uchida, T Matsuzawa
JournalJournal of nuclear medicine : official publication, Society of Nuclear Medicine (J Nucl Med) Vol. 18 Issue 8 Pg. 835-9 (Aug 1977) ISSN: 0161-5505 [Print] United States
PMID194935 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Gallium Radioisotopes
  • Radioisotopes
  • Indium
Topics
  • Animals
  • Carcinoma, Hepatocellular (analysis)
  • Gallium Radioisotopes (analysis)
  • Indium (analysis)
  • Liver (analysis)
  • Liver Neoplasms (analysis)
  • Lysosomes (analysis)
  • Neoplasm Transplantation
  • Neoplasms, Experimental (analysis)
  • Radioisotopes (analysis)
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: